We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Infectious Diseases – Products

A worker in a lab.
Product News

Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria

Glox Therapeutics, announced it has raised £4.3M in seed funding to develop effective targeted therapeutics against antibiotic-resistant Gram-negative bacteria.
A scientist behind a screen.
Product News

Armis Biopharma Announces Receipt of a $20.3 Million Contract with the Defense Threat Reduction Agency to Develop Veriox® DECON for Battlefield Wounds

Armis Biopharma, Inc. announced that the company received a $20.3 million contract from the Defense Threat Reduction Agency (DTRA) to develop its proprietary Veriox® DECON chemical warfare agent (CWA) decontamination product.
Double helix structure of DNA.
Product News

Oxford Nanopore Technologies and Fabric Genomics Collaborate To Launch an Integrated Whole-Genome Sequencing Solution

The partners will offer an integrated sample-to-report rapid nanopore sequencing analysis platform for neonatal/paediatric intensive care units to support clinicians in acute settings.
The corner of a macbook.
Product News

Oxford Nanopore Meets Apple’s M3 Silicon Chip

CEO Gordon Sanghera discusses how Apple’s latest product announcement means complex processing required for DNA/RNA sequencing can now be run from the latest MacBook Pro™ or iMac ™.

Applied Biosystems TaqPath COVID-19, Flu A/B, RSV Combo Kit: Multiplex PCR Test

Because RSV, influenza, and COVID-19 share symptoms, accurate testing is needed to distinguish one from the other. The CE-IVD marked multiplex TaqPath COVID-19, Flu A/B, RSV Combo Kit is specifically designed to detect and differentiate between these three viruses during flu season
The letters representing the DNA bases.
Product News

bioMérieux Makes Strategic Investment in Oxford Nanopore

Oxford Nanopore Technologies, announce that bioMérieux is making an immediate £70M investment in Oxford Nanopore.
Quantoom laboratory.
Product News

Gates Foundation To Accelerate mRNA Vaccine Innovation and Manufacturing in Africa and Globally

At the 2023 Grand Challenges Annual Meeting, Bill Gates, announced new investments to advance access to mRNA research and vaccine manufacturing technology that will support low- and middle-income countries.
A close up of someone holding a glass test tube.
Product News

Biovectra Signs Service Agreement With Acuitas Therapeutics for Unique Lipid Nanoparticle (Lnp) Delivery System Used in Manufacturing mRNA-Based Therapies

Partnership between two Canadian life sciences leaders offers a commercial GMP manufacturing solution for Acuitas’ licensed partners developing promising next generation therapies.
Double helix structure of DNA.
Product News

Evonetix Places First DNA Synthesis Development Platform at Imperial College London

External placement marks a key milestone in the development of Evonetix’s benchtop DNA synthesis technology, in preparation for customer use and commercialization.
The mRNA Therapeutics Boom

The Power of mRNA in Accelerating Therapeutic Development

mRNA-based therapies, from infectious disease vaccines to genetic disorder treatments, are gaining traction. However, mRNA purification methods must evolve beyond traditional precipitation techniques to meet the demands of large-scale therapeutic production.